Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Episode 134 | David Narrow, CEO at Sonavex | Commercial Strategy: Reimbursement, Limited Release, and Stakeholder Analysis

    Episode 134 | David Narrow, CEO at Sonavex | Commercial Strategy: Reimbursement, Limited Release, and Stakeholder Analysis

    FromProject Medtech

    Start listeningView podcast show

    Episode 134 | David Narrow, CEO at Sonavex | Commercial Strategy: Reimbursement, Limited Release, and Stakeholder Analysis

    FromProject Medtech

    ratings:
    Length:
    52 minutes
    Released:
    Apr 10, 2023
    Format:
    Podcast episode

    Description


    In this episode, David Narrow and Duane Mancini discuss the stagnant innovation in dialysis, reimbursement strategy, the strategy behind a limited market release, identifying various stakeholders and how they are incentivized, the importance of building your team, licensing from an University, and so much more.
    David Narrow LinkedIn
    Sonavex Website
    Project Medtech Website
    Project Medtech LinkedIn
    Duane Mancini LinkedIn
    Released:
    Apr 10, 2023
    Format:
    Podcast episode

    Titles in the series (100)

    Join us as we sit down with leading experts in the Medtech Industry as they share success stories, advice, pitfalls, trends and innovations.